Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT04546581Phase 3Completed
Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)
COVIDCOVID-19SARS (Severe Acute Respiratory Syndrome)+1 more
StudychairStart date: 2020-10-08
Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)
CancerCOVID-19HIV-1-infection+2 more
PrincipalinvestigatorStart date: 2020-05-11

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04546581Phase 3StudyChair

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

COVIDCOVID-19SARS (Severe Acute Respiratory Syndrome)+1 more
Completed
NCT04354818PrincipalInvestigator

Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)

CancerCOVID-19HIV-1-infection+2 more
Unknown

All 2 trials loaded